Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Ther Adv Med Oncol
; 15: 17588359221148921, 2023.
Article
en En
| MEDLINE
| ID: mdl-36743520
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Idioma:
En
Revista:
Ther Adv Med Oncol
Año:
2023
Tipo del documento:
Article
País de afiliación:
España